Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.470
+0.470 (15.67%)
At close: Nov 22, 2024, 4:00 PM
3.509
+0.039 (1.14%)
After-hours: Nov 22, 2024, 7:56 PM EST
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for CATX stock have an average target of 20.88, with a low estimate of 16 and a high estimate of 27. The average target predicts an increase of 501.73% from the current stock price of 3.47.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CATX stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 7 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $16 | Buy | Maintains | $22 → $16 | +361.10% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Reiterates $20 | Buy | Reiterates | $20 | +476.37% | Oct 24, 2024 |
| UBS | UBS | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +476.37% | Oct 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $22 | Buy | Reiterates | $22 | +534.01% | Oct 11, 2024 |
| Wedbush | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +620.46% | Oct 1, 2024 |
Financial Forecast
Revenue This Year
1.21M
from 1.43M
Decreased by -15.83%
Revenue Next Year
693.15K
from 1.21M
Decreased by -42.57%
EPS This Year
-0.86
from -1.74
EPS Next Year
-1.11
from -0.86
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.1M | 2.5M | 2.5M | |
| Avg | 1.2M | 693,151 | 688,500 | |
| Low | 833,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 45.0% | 107.0% | 263.6% | |
| Avg | -15.8% | -42.6% | -0.7% | |
| Low | -41.9% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.81 | -0.75 | -0.72 |
| Avg | -0.86 | -1.11 | -1.21 |
| Low | -0.93 | -1.75 | -1.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.